Structural Basis for Regulation of Phosphoinositide Kinases and Their Involvement in Human Disease

Burke, John E.·2018·Molecular Cell
DOI 10.1016/j.molcel.2018.08.005

Cited by (278)

Items 201–278 of 278

  1. Assessing the Presence of Phosphoinositides on Autophagosomal Membrane in Yeast by Live Cell Imaging
    Jing-Zhen Song, Yi-He Feng, Valentina Sergevnina, Jing Zhu, Hui Li, Zhiping Xie · 2024 · Microorganisms
  2. Oncogenic mutations of PIK3CA lead to increased membrane recruitment driven by reorientation of the ABD, p85 and C-terminus
    Meredith L. Jenkins, Harish Ranga-Prasad, Matthew AH Parson, Noah J Harris, Manoj Kumar Rathinaswamy, John E. Burke · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  3. Kinase Inhibitors for Targeted Cancer Therapy
    M. Amin Mir, Devalina Ray, Suman Mazumdar, Bimal Krishna Banik · 2025 · Current Topics in Medicinal Chemistry
  4. A computational framework for the investigation of phosphoinositide regulation
    Hilaire Yam Fung Cheung, Chukiat Tantiwong, Dipali Kale, Jonathan M. Gibbins, Steve P. Watson, Johan W. M. Heemskerk, Albert Sickmann, Robert Ahrends, Joanne L. Dunster · 2025 · PLoS Computational Biology
  5. Early phase development of PI3kinase inhibitors for anticancer therapies
    Carlo Caputo, Angela Lombardi, Miryam DEL VICARIO, Domenico Cautela, Raffaele Addeo, Federica Melisi, Anna Grimaldi, Alois Nečas, Evžen Amler, Rossella Sperlongano et al. · 2025 · Expert Opinion on Investigational Drugs
  6. A novel RAB5 binding site in human VPS34-CII that is likely the primordial site in eukaryotic evolution
    Saulė Špokaitė, Yohei Ohashi, Maxime Bourguet, Antoine Nicolas Dessus, Roger L. Williams · 2026 · eLife
  7. Rational Design of Potent and Orally Efficacious PI3Kα/δ Degrader for PIK3CA Mutant Breast Cancer without Hyperglycemic Liability
    Yi Hou, Xinqing Zheng, Yiwen Zhang, Hao Shen, Chenxun Kang, Han Qin, Shuyang Cao, Yasheng Zhu, Xing Wang, Chengliang Sun et al. · 2026 · Journal of Medicinal Chemistry
  8. Targeting PIP5K ameliorates hepatic cancer by inhibiting PI3K/AKT and the autophagy mechanism and enhancing ROS-mediated apoptosis
    P. A. Shantanu, Bishal Rajdev, Syamprasad NP, Jagadeesh Kumar Gangasani, Arijit Mandal, Samir Ranjan Panda, Ramakrishna Sistla, Sai Balaji Andugulapati, Shiv Kumar Sarin, Dinesh Mani Tripathi et al. · 2026 · Frontiers in Pharmacology
  9. Research progress of small molecule protein kinase inhibitors (SMKIs) in the treatment of colorectal cancer: mechanism, application, and future prospects
    Lu Liu, 陈颖君, Mingxin Guo, Fan Yun, Xifeng Li, Le Chen, Y M Li, Feng Li · 2026 · Frontiers in Pharmacology
  10. Phosphoinositide and redox dysregulation by the anticancer methylthioadenosine phosphorylase transition state inhibitor
    Timothy Salita, Yepy H. Rustam, Vinzenz Hofferek, Michael Jackson, Isaac Tollestrup, Jeffrey P. Sheridan, Vern L. Schramm, Gary B. Evans, Gavin E. Reid, Andrew B. Munkacsi · 2023 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  11. The rational design of ARUK2007145, a dual inhibitor of the α and γ isoforms of the lipid kinase phosphatidylinositol 5-phosphate 4-kinase (PI5P4K)
    Gregory G. Aldred, Timothy P. C. Rooney, Henriëtte M. G. Willems, Helen K. Boffey, Christopher Green, David Winpenny, John Skidmore, Jonathan H. Clarke, Stephen P. Andrews · 2023 · RSC Medicinal Chemistry
  12. Visualizing the dual interaction of calcineurin with PI4KA and FAM126A
    Qingtong Zhou, Xiao Liu, Ming‐Wei Wang · 2024 · Structure
  13. Orthosteric–allosteric dual inhibitors of PI5P4Kγ with potent antitumor activity in non-small cell lung cancer
    Xiong Liang, Lei Tang, Wenfeng Zhao, Rongtao Wang, Cheng Cheng, Daoping Wang, Yechun Xu, Lei Tang, Yanhua Fan · 2025 · Journal of Advanced Research
  14. Investigating potential molecular mechanisms of serum exosomal miRNAs in colorectal cancer based on bioinformatics analysis
    Haifeng Wang, Xiliang Chen, Lingling Bao, Xuede Zhang · 2020 · Medicine
  15. Molecular dissection of PI3Kβ synergistic activation by receptor tyrosine kinases, GβGγ, and Rho-family GTPases
    Benjamin R. Duewell, Naomi E. Wilson, Gabriela M. Bailey, Sarah E. Peabody, Scott D. Hansen · 2023 · eLife
  16. Demultiplexing overlapping signaling scaffold functions to probe lipid messenger coupling to cytoskeletal dynamics
    Nicholaus J. Trenton, Robert T. McLaughlin, Satya K. Bellamkonda, David Tsao, Emily Margaret Mace, Jordan Scott Orange, Volker Schweikhard, Michael R. Diehl · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  17. Transcription Factor EB regulates phosphatidylinositol-3-phosphate levels on endomembranes and alters lysosome positioning in the bladder cancer model
    Pallavi Mathur, Camilla de Barros Santos, Hugo Lachuer, Bruno Latgé, F. Radvanyi, B. Goud, Kristine Schauer · 2020 · bioRxiv
  18. Molecular assembly of measles and Nipah virus: specific lipid binding drives conformational change and matrix polymerization
    Michael J. Norris, Monica L. Husby, William Bill Kiosses, Jieyun Yin, Linda J. Rennick, Anja Heiner, Stephanie Harkins, Rudramani Pokhrel, Sharon L. Schendel, Kathryn M. Hastie et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  19. Epinephrine inhibits PI3K alpha via the Hippo kinases
    Ting-Yu Lin, Shakti Ramsamooj, Katarina M. Liberatore, Louise Lantier, Neil Vasan, Kannan R. Karukurichi, Seo‐Kyoung Hwang, Edward A. Kesicki, Edward R. Kastenhuber, Thorsten Wiederhold et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  20. Molecular Mechanisms and Physiological Significance of Organelle Interactions and Cooperation - Volume II
    Michael Schrader, M Islinger (21832286), J Costello (11103897) · 2022 · Frontiers research topics
  21. Allosteric activation or inhibition of PI3Kγ mediated through conformational changes in the p110γ helical domain
    Noah J Harris, Meredith L. Jenkins, Sung-Eun Nam, Manoj K Rathinaswamy, Matthew AH Parson, Harish Ranga-Prasad, Udit Dalwadi, Brandon E. Moeller, Eleanor Sheekey, Scott D. Hansen et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  22. Mechanisms controlling membrane recruitment and activation of autoinhibited SHIP1
    Grace L. Waddell, Emma E. Drew, Henry P. Rupp, Scott D. Hansen · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  23. Molecular dissection of PI3Kβ synergistic activation by receptor tyrosine kinases, GβGγ, and Rho-family GTPases
    Duewell, Benjamin R., Wilson, Naomi E., Bailey, Gabriela M., Peabody, Sarah E., Hansen, Scott D. · 2023
  24. Allosteric activation or inhibition of PI3Kγ mediated through conformational changes in the p110γ helical domain
    Noah J Harris, Meredith L. Jenkins, Sung-Eun Nam, Manoj Kumar Rathinaswamy, Matthew AH Parson, Harish Ranga-Prasad, Udit Dalwadi, Brandon E. Moeller, Eleanor Sheekey, Scott D. Hansen et al. · 2023 · eLife
  25. Role and Future Directions of PI3K Inhibitors in Cancer Treatment
    思远 郝 · 2023 · Hans Journal of Medicinal Chemistry
  26. Reviewer #2 (Public Review): Allosteric activation or inhibition of PI3Kγ mediated through conformational changes in the p110γ helical domain
    2023 · eLife
  27. Reviewer #1 (Public Review): Allosteric activation or inhibition of PI3Kγ mediated through conformational changes in the p110γ helical domain
    2023 · eLife
  28. Allosteric activation or inhibition of PI3Kγ mediated through conformational changes in the p110γ helical domain
    Noah J Harris, Meredith L. Jenkins, Sung-Eun Nam, Manoj Kumar Rathinaswamy, Matthew AH Parson, Harish Ranga-Prasad, Udit Dalwadi, Brandon E. Moeller, Eleanor Sheekey, Scott D. Hansen et al. · 2023 · eLife
  29. Author Response: Allosteric activation or inhibition of PI3Kγ mediated through conformational changes in the p110γ helical domain
    Noah J Harris, Meredith L. Jenkins, Sung-Eun Nam, Manoj K Rathinaswamy, Matthew AH Parson, Harish Ranga-Prasad, Udit Dalwadi, Brandon E. Moeller, Eleanor Sheekey, Scott D. Hansen et al. · 2023 · eLife
  30. Author response: Allosteric activation or inhibition of PI3Kγ mediated through conformational changes in the p110γ helical domain
    2023 · eLife
  31. Reconstitution of ORP-mediated lipid exchange process coupled to PI(4)P metabolism
    Nicolas Fuggetta, Nicola Rigolli, Maud Magdeleine, Agnese Seminara, Guillaume Drin · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  32. Molecular dissection of PI3Kβ synergistic activation by receptor tyrosine kinases, GβGγ, and Rho-family GTPases
    Benjamin R. Duewell, Naomi E. Wilson, Gabriela M. Bailey, Sarah E. Peabody, Scott D. Hansen · 2024 · eLife
  33. Enhanced PI3K/Akt Signaling in Response to p85α Loss is Regulated by Endosomal PI3Kα and PI3P
    Narendra Thapa, Mo Chen, Vincent L. Cryns, Richard Allen Anderson · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  34. Targeting Phosphatidyl-inositol-4-Phosphate-5-Kinase ameliorates hepatic cancer by inhibiting PI3K/Akt/mTOR and autophagy mechanism and enhancing ROS-mediated apoptosis
    P. A. Shantanu, Bishal Rajdev, Jagadeesh Kumar Gangasani, Syamprasad NP, Samir Ranjan Panda, Shiv Kumar Sarin, Dinesh Mani Tripathi, Sai Balaji Andugulapati, V.G.M. Naidu · 2024 · Research Square
  35. eLife Assessment: Allosteric activation or inhibition of PI3Kγ mediated through conformational changes in the p110γ helical domain
    Amy Hamilton Andreotti · 2023 · eLife
  36. Identifying novel heterozygous PI4KA variants in fetal abnormalities
    Cheng Chen, Fan Yang, Xinlin Chen, Sheng Zhao · 2025 · BMC Medical Genomics
  37. PAQR4: From spatial regulation of cell signaling to physiological homeostasis and diseases
    Z.-K. Jin, Zhi‐Qiang Ling · 2025 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  38. Recombinant Protein Biosensors of Cell Membrane Lipids
    Кольцова Екатерина Михайловна, Nikita Kolchin, E. I. Nikolaeva, Kirill R. Butov · 2025 · Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology
  39. STX-478, RLY-2608, and LOXO-783: third-generation PIK3CA mutant-selective allosteric inhibitors
    Yi Hou, Kai Yuan, Wenjian Min, Yasheng Zhu, Yang Peng · 2025 · Elsevier eBooks
  40. Decoding class II PI3K signaling: From membrane identity to human disease
    Roberta Rubino, Gabriele Squillero, Lorenzo Prever, Emanuele Fantastico, Maria Chiara De Santis, Arezou Kahnamouei, Federico Gulluni, Emilio Hirsch · 2025 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  41. Bi-allelic variants in the ribosomal protein RPS6KC1 cause a complex neurodevelopmental disorder
    Laura Planas‐Serra, Maria Esperanza Rodriguez-Ruiz, Eric Nathaniel Anderson, Agustí Rodríguez‐Palmero, Valentina Vélez-Santamaría, Agatha Schlüter, Edgard Verdura, Gorka Gereñu, Andrés Jiménez-Zúñiga, Alejandro Iñáñez et al. · 2025 · The American Journal of Human Genetics
  42. Additional file 1 of Aqueous extract of Platycodon grandiflorus attenuates lipopolysaccharide-induced apoptosis and inflammatory cell infiltration in mouse lungs by inhibiting PI3K/Akt signaling
    Zhou, Yang, Tianzi Jin, Gao, Mingtong, Zichen Luo, Mutahir, Sadaf, Shi, Chen, Tong Xie, Lin, Lili, Xu, Jianya, Yingzhao Liao et al. · 2023 · Figshare
  43. A novel RAB5 binding site in human VPS34-CII that is likely the primordial site in eukaryotic evolution
    Saulė Špokaitė, Yohei Ohashi, Maxime Bourguet, Antoine Nicolas Dessus, Roger Lee Williams · 2026 · eLife
  44. Phosphorylation of the C-terminus of PI4KA inhibits lipid kinase activity
    Alexandria L Shaw, Sophia Doerr, Hunter G. Nyvall, Meredith L. Jenkins, Sushant Suresh, Calvin K. Yip, Scott D. Hansen, John E. Burke · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  45. A novel RAB5 binding site in human VPS34-CII that is likely the primordial site in eukaryotic evolution
    Saulė Špokaitė, Yohei Ohashi, Maxime Bourguet, Antoine Nicolas Dessus, Roger Lee Williams · 2026 · eLife
  46. Identification d'une déficience humaine en SEC14L2 révélant son rôle dans le système immunitaire
    Débora Jorge Cordeiro · 2020
  47. Etudes des facteurs cellulaires et lipidiques déterminant la localisation du site d'assemblage et de bourgeonnement du VIH-1
    Baptiste Gonzales · 2019 · theses.fr (ABES)
  48. Exploring PI3K signalling dynamics in pancreatic cancer
    Carmen Fernanda Ramos Delgado · 2020 · theses.fr (ABES)
  49. Fonctionnement des échangeurs phosphatidylsérine / phosphatidylinositol 4-phosphate à l’interface entre le réticulum endoplasmique et la membrane plasmique
    Nicolas-Frédéric Lipp · 2020 · theses.fr (ABES)
  50. Role of TTC7A in the control of actin dynamics, leukocytes' migration and contribution to pathology
    Tania Gajardo · 2021 · theses.fr (ABES)
  51. Genetic, phenotypic and functional characterization of a cohort of patients with EBV-associated T/NK lymphoproliferations
    Benjamin Fournier · 2020 · theses.fr (ABES)
  52. Contrôle de l'oncogenicité de Kras et isoforme beta de PI3K dans la cancérogenèse du pancréas
    Silvia Arcucci · 2019 · theses.fr (ABES)
  53. Rôle de la phosphoinositide 3-kinase de classe II beta dans la dysfonction endothéliale lors d'un accident vasculaire cérébral ischémique
    Typhaine Anquetil · 2020 · theses.fr (ABES)
  54. Role of lysosome positioning in bladder cancer progression
    Pallavi Mathur · 2022 · theses.fr (ABES)
  55. Study of septin 9 in the cell polarity and development of cholangiocarcinoma
    Ting Cai · 2022 · theses.fr (ABES)
  56. Actin re-organization and lipid dynamics modulated by myosin 1b
    Gwendal Guérin · 2024
  57. Compounds mimicking the Michaelis-Menten transition state of the phosphatidylinositol 4-kinase
    Hubert Hřebabecký, Martin Klíma, Milan Dejmek, Pawel Krupa, Miguel Riopedre-Fernández, Eva Dávidová, Jakub Benýšek, Hector Martinez‐Seara, Bartosz Różycki, Evžen Bouřa et al. · 2026 · Bioorganic & Medicinal Chemistry
  58. A proximity-labeling map of PI5P4K phosphoinositide kinases interaction networks
    Alicia Llorente Lope, Gurpreet K. Arora, Ryan M. Loughran, Rabi Murad, Svetlana Maurya, Sophia Crabtree, Benji Portillo, Pratima Chapagain, Hundaol Huluka, Scott J. Eron et al. · 2026 · Journal of Biological Chemistry
  59. Probing Allosteric Kinase Modulators as Next Game-Changers in Fighting Neurodegeneration
    Elena Roggiolani, Michela Rosini, Anna Minarini, Filippo Basagni · 2026 · Journal of Medicinal Chemistry
  60. The antitumor promise of furo[2,3- d ]pyrimidine: a 2016–2025 review
    Mai A. Mansour, Haya A Elshafei, Alaa S. Sayed, Aya A. Ashour, Nadia E. Hussein, Marwan M. Abdel Karim, Fares M. Kamel, Nada T. Elsayed, Mahmoud R. Ahmed, Mohamed T. Seleem et al. · 2026 · RSC Advances
  61. The crosslink between autophagy and ferroptosis in polycystic ovary syndrome: from synergistic pathogenesis to targeted therapy
    Xujin Wu, Jiarui Li, Xuesong Zhang, Huili Huang, Tianjiao Li, Mingyue Kong, Ziqi Dai, Yihan Yang, Xin Chen · 2026 · Journal of Ovarian Research
  62. ARMH3 acts as a central scaffold at the Golgi/TGN through interactions with Arl5, GBF1, and PI4KB
    Mackenzie K. Scott, Giselle CT Klynsoon, Emma E. Walsh, Sushant Suresh, Hunter G. Nyvall, John E. Burke · 2026 · Journal of Biological Chemistry
  63. Recent advances in 1,3,5-triazine-based PI3K inhibitors for cancer therapy: a comprehensive review
    Utkarsha Kulkarni, Adarsh Yadav, Princy Desai, Clement Thangtinkhum, Drashti Shah, Afzal Nagani, Ashish Shah, Mehul Patel, Umang Shah, Swayamprakash Patel et al. · 2026 · Future Medicinal Chemistry
  64. PI4K and PIPK families in breast cancer: subtype-specific oncogenic mechanisms and precision therapeutic strategies
    Shanmei Du · 2026 · Molecular Biology Reports
  65. Reconstitution of Ras-PI3Kγ membrane communication and feedback using light-induced signaling inputs
    Sophia Doerr, Andres Olavarrieta Colasurdo, Scott D. Hansen · 2026 · Nature Communications
  66. A Rac-PI3Kβ feedback loop drives GPVI-dependent platelet activation
    Tom N. Durrant, James L. Hutchinson, Carl May, Justin S. Trory, Samantha Moore, Ingeborg Hers · 2026 · iScience
  67. PLCd4 signaling-mediated PI4P synthesis drives macrophage NLRP3 inflammasome activation to promote heat stroke-induced tissue injury
    Riqing Wei, Wenqian Zheng, Chenxin Liu, Dinghao Dang, Xinyu Deng, Xiaoting Hu, Hui Liang, Xi Luo, Jiayi Tang, Wei Zhu et al. · 2026 · Cell Reports
  68. Activation of the PI3K/AKT/mTOR signaling pathway in bladder cancer pathogenesis and its therapeutic significance
    Dereje E. Bogale · 2026 · Cancer Treatment and Research Communications
  69. Broad-spectrum host-targeting antivirals for rhinovirus infections: mechanisms and future perspectives
    Wanru Shang, Hongbin Luo, Siqi Li, Shichao Yu, Xinyu Wang, Dongye Fu, Lijun Wang, Fanzheng Meng, Man Gao · 2026 · Frontiers in Immunology
  70. Shenshuai Yingyang Jiaonang attenuates CKD-induced muscle atrophy: a role for Faecalibacterium prausnitzii and the EGFR/PI3K/AKT signaling axis
    Zhuoen He, Jinyue He, Chi Zhang, Hao Wang, Fujing Wang, Tingting Pei, Rong Hu, Zhiqiang Xian, Junfeng Li, Dinghui Liu et al. · 2026 · Phytomedicine
  71. Functional role of the second messengers PtdIns(3,4,5)P 3 and PtdIns(3,4)P 2 in carcinogenesis
    Nina Nelson, Manfred Jücker · 2026 · Biological Chemistry
  72. BindingDB Entry 50019333: The Identification of Potent, Selective, and Brain Penetrant PI5P4Kγ Inhibitors as In Vivo-Ready Tool Molecules.
    BindingDB · 2024 · UC San Diego
  73. BindingDB Entry 50016594: Kinase Inhibitors as Underexplored Antiviral Agents.
    BindingDB · 2023 · UC San Diego
  74. BindingDB Entry 50020015: The rational design of ARUK2007145, a dual inhibitor of the α and γ isoforms of the lipid kinase phosphatidylinositol 5-phosphate 4-kinase (PI5P4K).
    BindingDB · 2024 · UC San Diego
  75. BindingDB Entry 50015279: Development of Selective Phosphatidylinositol 5-Phosphate 4-Kinase γ Inhibitors with a Non-ATP-competitive, Allosteric Binding Mode.
    BindingDB · 2023 · UC San Diego
  76. BindingDB Entry 50019086: Identification of ARUK2002821 as an isoform-selective PI5P4Kα inhibitor.
    BindingDB · 2024 · UC San Diego
  77. BindingDB Entry 50021256: Advancements in dual-target inhibitors of PI3K for tumor therapy: Clinical progress, development strategies, prospects.
    BindingDB · 2025 · UC San Diego
  78. BindingDB Entry 50019988: Development of potent and selective degraders of PI5P4Kγ.
    BindingDB · 2024 · UC San Diego